SS-ECE nomogram: Prediction of Side Specific Extracapsular Extension at Radical Prostatectomy
Preoperative prediction of the probability of side specific extracapsular extension (SS-ECE) is a useful aid for most surgeons performing radical prostatectomy (RP). For less experienced surgeons it might represent the main indication for neurovascular bundle (NVB) excision or preservation. Its importance may be more marginal for very experienced surgeons.

The SS-ECE nomogram was externally validated and was highly accurate in a RALP population. 

The SS-ECE nomogram is recommended in the EAU-guidelines to assess the risk of ECE to support decision making regarding NVB excision during RP. 
Research authors: Thomas Steuber, Markus Graefen, Alexander Haese, Andreas Erbersdobler, Felix K.-H. Chun, Thorsten Schlom, Paul Perrotte, Hartwig Huland, Pierre I. Karakiewicz
Details Formula Study characteristics Files & References
★★★★
Model author
Model ID
1017
Version
1.2
Revision date
2017-11-08
Specialty
MeSH terms
  • Prostatectomy
  • Prostate Cancer
  • Nomogram
  • Prostate Specific Antigen
  • Gleason Score
  • Model type
    Logistic regression (Calculation)
    Status
    public
    Rating
    Share
    Formula
    No Formula defined yet
    Condition Formula

    Additional information

    Between January 1999 and December 2003 we performed a detailed, systematic assessment of biopsy and pathological information in 1,118 patients. These patients had biopsy proven, clinically localized prostate cancer and all underwent RP with or without staging lymphadenectomy (peritoneal lymph node dissection) at our institution. None received neoadjuvant or adjuvant androgen ablation, or radiotherapy. Their clinical and pathological information was converted to an SS format and analyzed as 2,236 prostate lobes.

    Study Population

    Total population size: 1118
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Continuous characteristics

    Name LL Q1 Median Q3 UL Unit
    PSA 0.1 6.6 73.2 ng/mL
    % pos cores/lobe 0 33.3 100 %
    % Ca/lobe 0 3.5 96 %

    Categorical characteristics

    Name Subset / Group Nr. of patients
    Clinical stage T1c 1835
    T2a 225
    T2b 109
    T2c 54
    T3 11
    Gleason sum 0 872
    4 or 5 42
    6 943
    7 (3 + 4) 262
    7 (4 + 3) 87
    8 or 9 29
    SS-ECE No 733
    Yes 385

    Probability of positive ECE is:
    ...

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Result
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Probability of positive ECE is:

    {{ resultSubheader }}
    {{ chart.title }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    Result interpretation

    Nerve-sparing RP can be performed safely in most men with localised prostate cancer (PCa). Clear contraindications are patients in whom there is a high risk of extracapsular disease, such as any cT2c or cT3 PCa, and any Gleason score (GS) > 7 on biopsy.

    This externally validated nomogram predicting side-specific extracapsular extension can help guide decision making.

    Multiparametric MRI might be helpful in selecting a nerve-sparing approach.


    If any doubt remains regarding residual tumour, the surgeon should remove the neurovascular bundle (NVB). Alternatively, the use of intra-operative frozen-section analysis can help guide these decisions. 

    Resource: EAU guideline prostate cancer. 

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.